Financhill
Back

Rhythm Pharmaceuticals Vs. Neurogene Industry Stock Comparison

Buy
85

RYTM
Rhythm Pharmaceuticals

Last Price:
61.04
Seasonality Move:
-0.27%
Sell
20

NGNE
Neurogene

Last Price:
25.04
Seasonality Move:
25.48%
Buy
85
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $62.04. The Score for RYTM is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
20
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $25.43. The Score for NGNE is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $62.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $25.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing slight selling pressure.

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 61.34 Buy
Chaikin Money Flow: 45915 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.05 - 63.59) Buy
Bollinger Bands (100): (45.6 - 56.38) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.36 Sell
Relative Strength Index (14 RSI): 38.76 Sell
Chaikin Money Flow: -108001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.71 - 58.79) Sell
Bollinger Bands (100): (30.89 - 51.17) Sell

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.56 Buy
20-day SMA: 60.04 Buy
50-day SMA: 54.12 Buy
200-day SMA: 46.03 Buy
8-day EMA: 60.91 Buy
20-day EMA: 59.04 Buy
50-day EMA: 55.23 Buy
200-day EMA: 46.7 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.11 Buy
20-day SMA: 39.58 Sell
50-day SMA: 43.45 Sell
200-day SMA: 38.56 Sell
8-day EMA: 25.61 Sell
20-day EMA: 33.37 Sell
50-day EMA: 39.56 Sell
200-day EMA: 36.94 Sell

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):